Connection

Andrew Kraft to Cyclin-Dependent Kinases

This is a "connection" page, showing publications Andrew Kraft has written about Cyclin-Dependent Kinases.
Connection Strength

0.465
  1. Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation. Blood. 1997 Nov 01; 90(9):3430-7.
    View in: PubMed
    Score: 0.139
  2. Inhibitors of cyclin-dependent kinase and cancer. J Mol Med (Berl). 1995 Oct; 73(10):509-14.
    View in: PubMed
    Score: 0.120
  3. Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res. 1995 Sep 01; 55(17):3716-20.
    View in: PubMed
    Score: 0.119
  4. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol Cell Biol. 2006 Oct; 26(20):7420-9.
    View in: PubMed
    Score: 0.064
  5. Regulation of the p58GTA cell division control-related protein kinase during phorbol 12-myristate 13-acetate-induced terminal differentiation of U937 cells. Oncogene. 1992 Mar; 7(3):501-6.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.